Sally C. Pipes
Commentary
A Public Option Is Still the Wrong Way to Reform Health Care
There’s nothing ‘moderate’ about the suffering that will result from the supposed ‘middle ground’ between the status quo and a single-payer system. California officials have recently fined L.A. Care, America’s largest publicly operated health-insurance program, $55 million for letting poor Angelenos suffer and die as they waited months to see ...
Commentary
The free market healthcare idea that blurs party and geographic lines
New survey data from the American Medical Association reveals that nearly 8 in 10 physicians believe the biggest barrier to offering telehealth is the “roll back of COVID-19 waivers, coverage, and payment policies.” That’s no surprise. When the pandemic hit, regulators waived restrictions that limited who could receive and how doctors could ...
Climate Change
Democrats’ Tone-Deafness on Medicare for All Costly
House Democrats haven’t given up on bringing socialized health care to the United States — at least judging from a hearing the Committee on Oversight and Reform held earlier this week. The event was titled “Examining Pathways to Universal Health Coverage.” But for the committee’s Democrats, the only pathway worth considering was a ...
Commentary
Under Government Health Care, The Doctor Won’t See You Now
In less than three weeks, the federal public health emergency for COVID-19 is set to expire. Some experts worry that the end of the emergency could unleash a flood of pent-up demand for health care—and add more stress to a health system already stretched thin. That’s because thousands of Americans—particularly seniors ...
Commentary
Facts, Economic Reason No Match for Left’s Drug Pricing Fixation
Last week, the U.S. Senate Finance Committee held a hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” It’s rare to see so many falsehoods in so few words. The idea that drug-price inflation is especially bad or that it poses some sort of threat to ...
Commentary
Government red tape would strangle patient access to medication
Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule. The accelerated approval pathway is a rare example of government working efficiently. ...
Health Technology
Trimming Red Tape Isn’t Just For Health Emergencies
The federal public health emergency prompted by the COVID-19 pandemic is set to expire in mid-April. Some states have already let their own emergency declarations lapse. It’s about time. COVID-19 is no longer the crisis it was back in 2020. Living in a permanent state of emergency is unsustainable. But that doesn’t ...
Commentary
The private sector can help solve our doctor shortage
The pandemic has laid bare a crisis we’ve ignored for far too long — our chronic doctor shortage. According to the Association of American Medical Colleges, the United States faces a shortfall of up to 124,000 physicians over the next decade. This is a supply problem, as the demand for ...
Commentary
States are eyeing a public option through rose-colored glasses
The Affordable Care Act will notch its 12th birthday later this month. To get the measure through Congress and to President Obama’s desk for his signature, Democrats had to cut one of progressives’ signature proposals—a public health insurance option. But the public option didn’t die all those years ago. President ...
Commentary
Light starts to shine on opaque drug pricing tactics
Late last month, the Federal Trade Commission announced it would seek public comments on the ways pharmacy benefit managers distort the prices of prescription drugs. PBMs deserve the scrutiny, as they’re to blame for much of the rise in prescription drug costs. Insurers hire PBMs to negotiate drug prices with ...
A Public Option Is Still the Wrong Way to Reform Health Care
There’s nothing ‘moderate’ about the suffering that will result from the supposed ‘middle ground’ between the status quo and a single-payer system. California officials have recently fined L.A. Care, America’s largest publicly operated health-insurance program, $55 million for letting poor Angelenos suffer and die as they waited months to see ...
The free market healthcare idea that blurs party and geographic lines
New survey data from the American Medical Association reveals that nearly 8 in 10 physicians believe the biggest barrier to offering telehealth is the “roll back of COVID-19 waivers, coverage, and payment policies.” That’s no surprise. When the pandemic hit, regulators waived restrictions that limited who could receive and how doctors could ...
Democrats’ Tone-Deafness on Medicare for All Costly
House Democrats haven’t given up on bringing socialized health care to the United States — at least judging from a hearing the Committee on Oversight and Reform held earlier this week. The event was titled “Examining Pathways to Universal Health Coverage.” But for the committee’s Democrats, the only pathway worth considering was a ...
Under Government Health Care, The Doctor Won’t See You Now
In less than three weeks, the federal public health emergency for COVID-19 is set to expire. Some experts worry that the end of the emergency could unleash a flood of pent-up demand for health care—and add more stress to a health system already stretched thin. That’s because thousands of Americans—particularly seniors ...
Facts, Economic Reason No Match for Left’s Drug Pricing Fixation
Last week, the U.S. Senate Finance Committee held a hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” It’s rare to see so many falsehoods in so few words. The idea that drug-price inflation is especially bad or that it poses some sort of threat to ...
Government red tape would strangle patient access to medication
Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule. The accelerated approval pathway is a rare example of government working efficiently. ...
Trimming Red Tape Isn’t Just For Health Emergencies
The federal public health emergency prompted by the COVID-19 pandemic is set to expire in mid-April. Some states have already let their own emergency declarations lapse. It’s about time. COVID-19 is no longer the crisis it was back in 2020. Living in a permanent state of emergency is unsustainable. But that doesn’t ...
The private sector can help solve our doctor shortage
The pandemic has laid bare a crisis we’ve ignored for far too long — our chronic doctor shortage. According to the Association of American Medical Colleges, the United States faces a shortfall of up to 124,000 physicians over the next decade. This is a supply problem, as the demand for ...
States are eyeing a public option through rose-colored glasses
The Affordable Care Act will notch its 12th birthday later this month. To get the measure through Congress and to President Obama’s desk for his signature, Democrats had to cut one of progressives’ signature proposals—a public health insurance option. But the public option didn’t die all those years ago. President ...
Light starts to shine on opaque drug pricing tactics
Late last month, the Federal Trade Commission announced it would seek public comments on the ways pharmacy benefit managers distort the prices of prescription drugs. PBMs deserve the scrutiny, as they’re to blame for much of the rise in prescription drug costs. Insurers hire PBMs to negotiate drug prices with ...
